Arthur C. Mok
Partner
Arthur Mok advises global leaders in the life sciences industry, with a specific emphasis on representing biotechs, multinational pharmaceutical companies and sector specialist investment sponsors on matters centered on the greater China region. Arthur is also a member of the firm’s governing Policy Committee and serves as the regional managing partner of the firm’s Asia offices. He is the founding partner of the firm’s Shanghai office.
With nearly two decades of on-the-ground experience in China, Arthur is regularly called upon by C-suite executives, board members and financial advisors for his insight into the opportunities and challenges presented by China’s life sciences industry. His deep understanding of regional trends also makes him a trusted advisor to leaders in the field. Clients say that Arthur is a “great business adviser” with “excellent judgement,” as reported to Chambers Greater China Region, where Arthur is ranked Band 1. His work for investment sponsors has also resulted in his top rankings in the IFLR 1000.
Publications
- Quoted, “Ropes & Gray Appoints New Hong Kong Head, Goes ‘All In for Life Sciences,’” Law.com (March 10, 2022)
- Quoted, “Pharma Frenzy,” Asian Legal Business China (July 2021)
- Quoted, “Ropes Names Special Situations Co-Head as New Hong Kong MP,” Asian Legal Business (November 29, 2017)
- Quoted, “Asia-Pacific 150: The big market slowdown,” The Lawyer (27 June 2016)
- Quoted, “Ropes & Gray lawyer returns from senior APAC in-house role,” Australasian Lawyer (Nov. 13, 2018)
- Quoted, “Investors rush Into China health care,” Healthcare Asia Daily (April 21, 2014)
- Quoted, “China Health Care Sees Record Deals,” The Wall Street Journal (March 25, 2014)
- Featured, “Arthur Mok Has Joined Ropes & Gray,” Asia IP (December 14, 2012)
- Mentioned, “Ropes & Gray Shanghai bulks up with senior Hogan Lovells IP hire,” The Lawyer (September 7, 2011)
- Featured, “Ropes & Gray Opens Shanghai Office,” The AmLaw Daily (July 21, 2011)
- Quoted, “Ropes & Gray opens Shanghai base,” The Lawyer (July 21, 2011)
Admissions / Qualifications
Qualifications
- District of Columbia, 1998
Awards
- Chambers Asia-Pacific and Greater China: Leading Lawyer in Life Sciences (2012-2023)
- Legal 500 Asia-Pacific: A Leading Individual in Healthcare & Life Science in China (2021, 2023)
- Legal 500 Asia-Pacific: Hall of Fame in Private Equity/Venture Capital, China (2021-2023)
- IFLR 1000: The Guide to the World’s Leading Financial Law Firms (2013-2022)
- IFLR1000: Highly Regarded (2023)
- Asian Legal Business China: Top 15 M&A Lawyers – International Law Firms (2020)
- China Business Law Journal: The A-List of China’s Top 100 Lawyers (2019)
- In-House Community: Commended External Counsel of the Year in China (2018)
- Chambers Asia: Asia's Leading Lawyers in Private Equity, China (2009-2018)
- Client Choice Awards: the exclusive winner of China Healthcare & Life Sciences (2018)
- Who's Who Legal: Life Sciences (2015-2022)
- Chambers Global: The World’s Leading Lawyers for Business (2016-2022)
- Asialaw’s Leading Lawyers (2013)
- Who's Who Legal: Thought Leaders (2021-2022)
